Autor: "Ding K" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Synergistically Anti-Multiple Myeloma Effects: Flavonoid, Non-Flavonoid Polyphenols, and Bortezomib.
Autorzy:: Ding K; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
Jiang W; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
Jia H; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.
Lei M; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610075, China.; Pokaż więcej
Źródło:: Biomolecules [Biomolecules] 2022 Nov 07; Vol. 12 (11). Date of Electronic Publication: 2022 Nov 07.
Typ publikacji:: Systematic Review; Journal Article; Review
MeSH Terms:: Multiple Myeloma*/drug therapy
Multiple Myeloma*/pathology
Antineoplastic Agents*/pharmacology
Humans ; Bortezomib/pharmacology ; Polyphenols/pharmacology ; Polyphenols/therapeutic use ; Apoptosis ; Molecular Targeted Therapy ; Cell Line, Tumor ; Drug Resistance, Neoplasm

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: JND4135, a New Type II TRK Inhibitor, Overcomes TRK xDFG and Other Mutation Resistance In Vitro and In Vivo.
Autorzy:: Wang J; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, Ministry of Education (MoE) of People's Republic of China, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
Zhou Y; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, Ministry of Education (MoE) of People's Republic of China, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
Tang X; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, Ministry of Education (MoE) of People's Republic of China, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
Yu X; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, Ministry of Education (MoE) of People's Republic of China, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
Wang Y; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, Ministry of Education (MoE) of People's Republic of China, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
Chan S; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, Ministry of Education (MoE) of People's Republic of China, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
Song X; Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, 190 Kaiyuan Avenue, Guangzhou Science Park, Guangzhou 510530, China.
Tu Z; Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, 190 Kaiyuan Avenue, Guangzhou Science Park, Guangzhou 510530, China.
Zhang Z; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, Ministry of Education (MoE) of People's Republic of China, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
Lu X; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, Ministry of Education (MoE) of People's Republic of China, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
Zhang Z; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, Ministry of Education (MoE) of People's Republic of China, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.
Ding K; International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, Ministry of Education (MoE) of People's Republic of China, College of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou 510632, China.; State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, #345 Lingling Road, Shanghai 200032, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2022 Oct 01; Vol. 27 (19). Date of Electronic Publication: 2022 Oct 01.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Neoplasms*/drug therapy
Neoplasms*/genetics
Neoplasms*/pathology
Animals ; Humans ; Mice ; Mutation ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Receptor, trkA/genetics ; Receptor, trkA/metabolism ; Tropomyosin

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Flavonoids Regulate Inflammation and Oxidative Stress in Cancer.
Autorzy:: Li G; Institute (College) of Integrative Medicine, Dalian Medical University, Dalian 116044, China.
Ding K; Institute (College) of Integrative Medicine, Dalian Medical University, Dalian 116044, China.
Qiao Y; Institute (College) of Integrative Medicine, Dalian Medical University, Dalian 116044, China.
Zhang L; Institute (College) of Integrative Medicine, Dalian Medical University, Dalian 116044, China.
Zheng L; Institute (College) of Integrative Medicine, Dalian Medical University, Dalian 116044, China.
Pan T; Institute (College) of Integrative Medicine, Dalian Medical University, Dalian 116044, China.
Zhang L; Institute (College) of Integrative Medicine, Dalian Medical University, Dalian 116044, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2020 Nov 30; Vol. 25 (23). Date of Electronic Publication: 2020 Nov 30.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Anti-Inflammatory Agents/*pharmacology
Antineoplastic Agents/*pharmacology
Antioxidants/*pharmacology
Flavonoids/*pharmacology
Inflammation/*drug therapy
Neoplasms/*drug therapy
Oxidative Stress/*drug effects
Animals ; Humans ; Inflammation/pathology ; Neoplasms/pathology ; Signal Transduction

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: The economic impact of the transition from branded to generic oncology drugs.
Autorzy:: Cheung WY; University of Calgary, Calgary, AB.
Kornelsen EA; University of Calgary, Calgary, AB.
Mittmann N; University of Toronto, Toronto, ON.
Leighl NB; University of Toronto, Toronto, ON.
Cheung M; University of Toronto, Toronto, ON.
Chan KK; University of Toronto, Toronto, ON.
Bradbury PA; University of Toronto, Toronto, ON.
Ng RCH; University of Toronto, Toronto, ON.
Chen BE; Queen's University, Kingston, ON.
Ding K; Queen's University, Kingston, ON.
Pater JL; Queen's University, Kingston, ON.
Tu D; Queen's University, Kingston, ON.
Hay AE; Queen's University, Kingston, ON.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2019 Apr; Vol. 26 (2), pp. 89-93. Date of Electronic Publication: 2019 Apr 01.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Agents/*economics
Drugs, Generic/*economics
Lung Neoplasms/*economics
Lymphoma/*economics
Antineoplastic Agents/therapeutic use ; Cetuximab/economics ; Cetuximab/therapeutic use ; Cisplatin/economics ; Cisplatin/therapeutic use ; Cost-Benefit Analysis ; Cytarabine/economics ; Cytarabine/therapeutic use ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/economics ; Deoxycytidine/therapeutic use ; Dexamethasone/economics ; Dexamethasone/therapeutic use ; Drug Costs ; Drugs, Generic/therapeutic use ; Erlotinib Hydrochloride/economics ; Erlotinib Hydrochloride/therapeutic use ; Humans ; Lung Neoplasms/drug therapy ; Lymphoma/drug therapy ; Randomized Controlled Trials as Topic ; Vinorelbine/economics ; Vinorelbine/therapeutic use ; Gemcitabine

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Shikonin sensitizes wild‑type EGFR NSCLC cells to erlotinib and gefitinib therapy.
Autorzy:: Li YL; Department of Clinical Pharmacology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, P.R. China.
Hu X; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China.
Li QY; Department of Clinical Pharmacology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, P.R. China.
Wang F; Department of Clinical Pharmacology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, P.R. China.
Zhang B; Hangzhou Translational Medicine Research Center, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, P.R. China.
Ding K; Department of Clinical Pharmacology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, P.R. China.
Tan BQ; Department of Clinical Pharmacology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, P.R. China.
Lin NM; Department of Clinical Pharmacology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310006, P.R. China.
Zhang C; School of Medicine, Zhejiang University City College, Hangzhou, Zhejiang 310015, P.R. China.; Pokaż więcej
Źródło:: Molecular medicine reports [Mol Med Rep] 2018 Oct; Vol. 18 (4), pp. 3882-3890. Date of Electronic Publication: 2018 Aug 03.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents/*pharmacology
Carcinoma, Non-Small-Cell Lung/*drug therapy
Erlotinib Hydrochloride/*pharmacology
Gefitinib/*pharmacology
Lung Neoplasms/*drug therapy
Naphthoquinones/*pharmacology
A549 Cells ; Animals ; Apoptosis/drug effects ; Carcinoma, Non-Small-Cell Lung/metabolism ; Carcinoma, Non-Small-Cell Lung/pathology ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/metabolism ; Humans ; Lithospermum/chemistry ; Lung Neoplasms/metabolism ; Lung Neoplasms/pathology ; Mice, Nude ; Naphthoquinones/chemistry ; Protein Kinase Inhibitors/pharmacology ; Reactive Oxygen Species/metabolism